Strikingly, the improvements in whole-body insulin sensitivity were more pronounced in individuals with the lowest baseline insulin sensitivity, underlining the potential of hypoxia exposure as a therapy for people with (severe) insulin resistance. The gene discussed is INS; the disease is Insulin resistance.